This Week One More IPO

Concord Biotech Limited IPO

Concord Biotech Limited Incorporated In 1984, Concord Biotech Limited Is an India-based R&D-driven Biopharma Company. The Company Is Ranked Among The Leading Global Developers And Manufactures Of Select Fermentation-based APIs Across Immunosuppressants And Oncology In Terms Of Market Share, Based On Volume In 2022

 Concord Biotech Limited IPO Open And Close Date

Open 04 AUGUST 2023

Close 08 AUGUST 2023

Basis of Allotment 11 AUGUST 2023

Initiation Of Refunds 14 AUGUST 2023

Credit Of Shares To Demat 17 AUGUST 2023

Listing Date 18 AUGUST 2023

Concord Biotech Limited IPO 

Price Details 

Price: ₹ 705 - ₹ 741

Face Value: ₹ 1

Lot Size: 20 Shares 

Issue Size: ₹ 1,550.52 Cr

Concord Biotech Limited IPO 

Reservation 

Retail Shares: 35%

QIB Shares : 50%

HII Shares: 15%

Retail Shares: 20 App Amt: ₹ 14,820 Retail Forms: 366,024

Small Hni (2-10 Lakh) Shares: 280 App Amt: ₹ 207,480 Forms: 3735

Big Hni (10+ Lakh) Shares: 1360 App Amt: ₹ 1,007,760 Forms: 7470

Disclaimer - Myself Uttam Nirmal Pradhan the information contained in this is provided from my own suggestion and not be taken legally